Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 32NIH 6INDUSTRY 5NETWORK 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Teratoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Biphenotypic, Acute 1Ependymoma 1Choriocarcinoma 1Carcinoma, Embryonal 1Burkitt Lymphoma 1

Interventions

Specimen Handling 46Magnetic Resonance Spectroscopy 37Cyclophosphamide 28Vincristine 20Radiation 19Dexamethasone 19Cisplatin 18Biopsy 18Radiotherapy 17Etoposide 17Carboplatin 16Cytarabine 13Leucovorin 12daratumumab 11Methotrexate 11durvalumab 10Standard of Care 10Radiotherapy, Intensity-Modulated 10Platinum 10Gemcitabine 10Doxorubicin 10Docetaxel 10Practice Guidelines as Topic 9Calcium Dobesilate 91,2-diaminocyclohexaneplatinum II citrate 9merphos 8dexamethasone acetate 8dexamethasone 21-phosphate 8auricularum 8X-Rays 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Granulocyte Colony-Stimulating Factor × 90 days × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

NCT03007147 2026-05-04

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Active not recruiting
475 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

NCT02436707 2026-04-20

Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma

Canadian Cancer Trials Group

Phase 2 Active not recruiting
129 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡